TREX1 p.Val201Asp
c.602T>A · rs78408272 · VCV4182
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9294 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.821 | moderately pathogenic-leaning |
| SaProt | LLR -13.91 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 4.1 | GERP 1.8, phastCons 1 |
| Regional constraint | o/e 1.01 | unconstrained · MANE · 941 bp · p 0.82 · regional, not allelic |
| Overall | ||
| CADD | 25.5 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- TREX1
- Protein
- p.Val201Asp
- Coding
- c.602T>A
- MANE Select
- NM_130384 · reported on NM_033629
- dbSNP
- rs78408272
- Type
- single nucleotide variant
- Location
- chr3:48467257 (GRCh38)
Disease context
Aicardi-Goutieres syndrome 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Aicardi-Goutières syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- Antenatal, Infancy, Neonatal
- Prevalence
- 1-5 / 10 000 (Europe)
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/trex1-p-val201asp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown